Laobaixing Pharmacy (603883) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.075x

Based on the latest financial reports, Laobaixing Pharmacy (603883) has a cash flow conversion efficiency ratio of 0.075x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥538.25 Million ≈ $78.76 Million USD) by net assets (CN¥7.20 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603883 stock market capitalisation for the company's overall valuation and market capitalisation.

Laobaixing Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Laobaixing Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laobaixing Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laobaixing Pharmacy ranked by their cash flow conversion efficiency. Explore Laobaixing Pharmacy (603883) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Longshine Technology Co Ltd SHE:300682	0.021x
Bolsas y Mercados Argentinos SA BA:BYMA	0.016x
Sundaram Finance Holdings Limited NSE:SUNDARMHLD	0.032x
Avalyn Pharma Inc. Common Stock NASDAQ:AVLN	-0.065x
Hangzhou DPtech Technologies Co Ltd SHE:300768	0.013x
Playa Hotels & Resorts BV F:PL0	0.147x
Wuxi Shangji Automation Co Ltd SHG:603185	0.054x
Hubei Jianghan New Materials Co. Ltd. A SHG:603281	N/A

Annual Cash Flow Conversion Efficiency for Laobaixing Pharmacy (2011–2025)

The table below shows the annual cash flow conversion efficiency of Laobaixing Pharmacy from 2011 to 2025. View Laobaixing Pharmacy (603883) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.00 Billion ≈ $1.02 Billion	CN¥3.14 Billion ≈ $459.87 Million	0.449x	+58.91%
2024-12-31	CN¥7.17 Billion ≈ $1.05 Billion	CN¥2.03 Billion ≈ $296.53 Million	0.283x	-24.52%
2023-12-31	CN¥7.29 Billion ≈ $1.07 Billion	CN¥2.73 Billion ≈ $399.46 Million	0.375x	+14.86%
2022-12-31	CN¥7.10 Billion ≈ $1.04 Billion	CN¥2.31 Billion ≈ $338.66 Million	0.326x	-32.20%
2021-12-31	CN¥4.78 Billion ≈ $699.30 Million	CN¥2.30 Billion ≈ $336.31 Million	0.481x	+59.66%
2020-12-31	CN¥4.81 Billion ≈ $703.18 Million	CN¥1.45 Billion ≈ $211.81 Million	0.301x	+13.04%
2019-12-31	CN¥3.87 Billion ≈ $567.00 Million	CN¥1.03 Billion ≈ $151.09 Million	0.266x	-1.66%
2018-12-31	CN¥3.37 Billion ≈ $493.04 Million	CN¥913.03 Million ≈ $133.60 Million	0.271x	+70.76%
2017-12-31	CN¥3.10 Billion ≈ $453.79 Million	CN¥492.13 Million ≈ $72.01 Million	0.159x	-1.45%
2016-12-31	CN¥1.95 Billion ≈ $284.66 Million	CN¥313.26 Million ≈ $45.84 Million	0.161x	+43.53%
2015-12-31	CN¥2.29 Billion ≈ $335.39 Million	CN¥257.15 Million ≈ $37.63 Million	0.112x	-50.72%
2014-12-31	CN¥1.09 Billion ≈ $158.86 Million	CN¥247.14 Million ≈ $36.17 Million	0.228x	+52.82%
2013-12-31	CN¥916.46 Million ≈ $134.11 Million	CN¥136.52 Million ≈ $19.98 Million	0.149x	-26.69%
2012-12-31	CN¥732.59 Million ≈ $107.20 Million	CN¥148.85 Million ≈ $21.78 Million	0.203x	-6.94%
2011-12-31	CN¥607.41 Million ≈ $88.88 Million	CN¥132.62 Million ≈ $19.41 Million	0.218x	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.44 Billion

CN¥9.82 Billion CNY

Market Cap Rank

#7476 Global

#1650 in China

Share Price

CN¥12.94

Change (1 day)

+0.47%

52-Week Range

CN¥10.96 - CN¥17.57

All Time High

CN¥331.82